CapsoVision, Inc. Common Stock (CV) is a publicly traded Healthcare sector company. As of July 11, 2026, CV trades at $5.91 with a market cap of $288.29M and a P/E ratio of 13.80. CV moved +3.29% today. Year to date, CV is -43.97%; over the trailing twelve months it is +33.11%. Its 52-week range spans $3.43 to $15.37. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces CV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CV combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.91 |
| Market Cap | $288.29M |
| P/E Ratio | 13.80 |
| EPS | $0.43 |
| Dividend Yield | 0.23% |
| 52-Week High | $15.37 |
| 52-Week Low | $3.43 |
| Volume | 53.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $358.89M |
| Net Income | $6.15M |
| Gross Margin | 0.00% |
1 analysts cover CV: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.